Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSABP R-04: Preoperative Chemoradiotherapy with Capecitabine, 5-FU, and Oxaliplatin in Rectal Cancer
NCT00058474Phase 3Unknown
- Sponsor
- NSABP Foundation
- Start
- Jul 2004
- Primary completion
- Aug 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of capecitabine, oxaliplatin in rectal cancer, sponsored by NSABP Foundation. Status: unknown.
02
Drugs
capecitabineoxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00058474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058474.